検索結果 - Minal A. Barve

  • 検索結果 1 - 1 結果 / 1
結果の絞り込み
  1. 1
    Five‐year results of a phase II trial of preoperative 5‐fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2‐positive patients) for patients with stage II or III breast cancer

    Five‐year results of a phase II trial of preoperative 5‐fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2‐positive... 著者: Frankie Ann Holmes, Beth A. Hellerstedt, John E. Pippen Jr., Svetislava J. Vukelja, Rufus P. Collea, Darren M. Kocs, Joanne L. Blum, Kristi J. McIntyre, Minal A. Barve, Barry D. Brooks, Cynthia R. Osborne, Yunfei Wang, Lina Asmar, Joyce O'Shaughnessy

    出版事項 2018-06-01

    Abstract We aimed to increase pathologic complete response (pCR) in patients with invasive breast cancer by adding preoperative capecitabine to docetaxel following 5‐fluorouracil, epirubicin, cyclophosphamide (FEC) (with trastuzumab for patients with HER2‐positive disease) and to evaluate 5‐year dis...

    詳細記述

    全文の入手
    論文

    お気に入りに追加
    保存先:

検索ツール: